Controversy

Can conventional + advanced MRI reliably separate intramedullary neoplasm from non-neoplastic myelopathy?

Evidence profile

Status: awaiting_review. Rule: atlas-profile-2.0.

3 linked publications; not a count of independent studies.

Missing appraisal does not mean no evidence exists. Inspect the full profile and source relationships in the interactive Atlas.

Historical grade: WEAK (retained from 22 September 2026; not a completed profile 2.0 assessment).

Position A

DTI/tractography and enhancement/morphology patterns differentiate tumor from inflammatory/compressive myelopathy

Position B

Spondylotic and inflammatory myelopathy routinely mimic intramedullary tumor; biopsy is still often required

Clinical stakes

A wrong call sends a patient to cord biopsy/resection or to immunotherapy; stakes are very high with genuine overlap.

Open in the interactive atlas →

About this page

Curated and maintained by Resonant Labs. Editorial lead: Claims are synthesized from the cited literature and graded per the Atlas methodology (about the Atlas). Page generated 2026-10-02. This is not a new clinical review date.

This is an educational research resource from Resonant Labs, not clinical advice. Atlas assessments are heuristic, not probabilities or formal GRADE ratings. Findings are summarized from the literature and may change as the field evolves.